These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4124093)

  • 1. Long plasma half-life of pyrimethamine.
    Nichol CA
    Lancet; 1973 Jul; 2(7821):161. PubMed ID: 4124093
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma half-lives and the excretion into egg-white and -yolk of three sulponamides and pyrimethamine after medication of laying hens.
    Blom L
    Acta Pharmacol Toxicol (Copenh); 1975 Jul; 37(1):79-93. PubMed ID: 240246
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Pyrimethamine in central-nervous-system leukaemia.
    Carrera Boadella A; Pla Illa RP
    Lancet; 1973 Dec; 2(7841):1330. PubMed ID: 4127678
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma concentrations of sulfadoxine-pyrimethamine, mefloquine and its main metabolite after regular malaria prophylaxis for two years.
    Hellgren U; Angel VH; Bergqvist Y; Forero-Gomez JS; Rombo L
    Trans R Soc Trop Med Hyg; 1991; 85(3):356-7. PubMed ID: 1949137
    [No Abstract]   [Full Text] [Related]  

  • 5. Pyrimethamine in central-nervous-system leukaemia.
    Ragab AH
    Lancet; 1973 May; 1(7811):1061. PubMed ID: 4122138
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Pyrimethamine in prophylaxis of meningeal leukaemia.
    Hamers J; van Hove W; Baele G
    Lancet; 1974 Feb; 1(7852):310-1. PubMed ID: 4130488
    [No Abstract]   [Full Text] [Related]  

  • 7. Monitoring of plasma concentration of pyrimethamine (PYR) in infants with congenital Toxoplasma gondii infection--own observations.
    Lipka B; Milewska-Bobula B; Filipek M
    Wiad Parazytol; 2011; 57(2):87-92. PubMed ID: 21682092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Teratogenic effect of pyrimethamine in the rat. In vivo prevention by calcium folinate].
    Horvath C; Compagnon A; Petter C
    C R Seances Soc Biol Fil; 1988; 182(2):158-66. PubMed ID: 2973823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting, repository antimalarial agents. Duration of protection in mice and monkeys following administration of pyrimethamine pamoate.
    Werbel LM; Jacobs RL; Steinkampf RW; Worth DF
    Am J Trop Med Hyg; 1984 Jul; 33(4):526-33. PubMed ID: 6236702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid gas chromatographic determination of pyrimethamine in human plasma and urine.
    Midskov C
    J Chromatogr; 1984 Mar; 306():388-93. PubMed ID: 6715478
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacokinetic aspects of a pyrimethamine combination with sulfanilamides].
    Lur'e AA; Shcherbakov AM; Lue TV; Nguyen TN; Le DD
    Med Parazitol (Mosk); 1986; (4):10-5. PubMed ID: 3531793
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life.
    Watkins WM; Mosobo M
    Trans R Soc Trop Med Hyg; 1993; 87(1):75-8. PubMed ID: 8465404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the determination and degradation of pyrimethamine in mammals.
    Kumar R; Kaushik P; Sharma CB
    Biomed Chromatogr; 1990 Jul; 4(4):165-7. PubMed ID: 2207379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of sulfadoxine and pyrimethamine after Fansidar administration in man.
    Edstein MD
    Chemotherapy; 1987; 33(4):229-33. PubMed ID: 3608621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple-dose pharmacokinetics of the antimalarial drug Fansimef (pyrimethamine + sulfadoxine + mefloquine) in healthy subjects.
    Schwartz DE; Weidekamm E; Mimica I; Heizmann P; Portmann R
    Chemotherapy; 1987; 33(1):1-8. PubMed ID: 3493885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary elimination of pyrimethamine.
    Ahmad RA; Rogers HJ
    Br J Clin Pharmacol; 1981 Jan; 11(1):101-2. PubMed ID: 7213501
    [No Abstract]   [Full Text] [Related]  

  • 17. Excretion of chloroquine, dapsone and pyrimethamine in human milk.
    Edstein MD; Veenendaal JR; Newman K; Hyslop R
    Br J Clin Pharmacol; 1986 Dec; 22(6):733-5. PubMed ID: 3567020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic method for the determination of pyrimethamine and its 3-N-oxide metabolite in biological fluids.
    Coleman MD; Edwards G; Mihaly GW; Howells RE; Breckenridge AM
    J Chromatogr; 1984 Jun; 308():363-9. PubMed ID: 6746829
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of micronucleus induction of pyrimethamine in in vitro CHL cells and in in vivo mouse bone marrow cells.
    Ono T; Yoshimura H
    Mutagenesis; 1996 Jan; 11(1):85-8. PubMed ID: 8671721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrimethamine in central-nervous-system leukaemia.
    Price LA
    Lancet; 1973 Jun; 1(7815):1315. PubMed ID: 4126098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.